ロード中...
IGF-1 and Anti-VEGF in ROP: Has the time come?
Treatment of ROP is currently evolving. Novel therapeutic options are emerging that have the potential to complement existing therapies and improve treatment outcomes. However, any new therapeutic options must be thoroughly evaluated before existing (and successful) treatment paradigms can be amende...
保存先:
| 主要な著者: | , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2014
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4197141/ https://ncbi.nlm.nih.gov/pubmed/25300950 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000365132 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|